⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2590105 | 1.00 | — | — | |
| SCHEMBL2163678 | 0.77 | — | — | |
| SCHEMBL2163677 | 0.77 | — | — | |
| SCHEMBL2163713 | 0.74 | — | — | |
| SCHEMBL2163715 | 0.74 | — | — | |
| SCHEMBL2162929 | 0.70 | — | — | |
| SCHEMBL4956489 | 0.70 | — | — | |
| SCHEMBL4958294 | 0.70 | — | — | |
| SCHEMBL2162883 | 0.70 | — | — | |
| SCHEMBL27451254 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0636022-A1 | CHEMICAL PREVENTION OR REVERSAL OF CATARACT BY PHASE SEPARATION INHIBITORS | OCULON CORPORATION (US) | 1995-02-01 | — | — | EP | disclosed |
| WO-1994026259-A1 | CHEMICAL PREVENTION OR REVERSAL OF CATARACT BY PHASE SEPARATION INHIBITORS | OCULON CORPORATION (US) | 1994-11-24 | — | — | WO | disclosed |
| US-5338545-A | Administering Coenzyme A | OCULON CORPORATION (US) | 1994-08-16 | — | — | US | disclosed |
| WO-1993020805-A1 | CHEMICAL PREVENTION OR REVERSAL OF CATARACT BY PHASE SEPARATION INHIBITORS | OCULON CORPORATION (US) | 1993-10-28 | — | — | WO | disclosed |